Increase decrease in sublicense percentage based on revenues.

No definition available.

Name:	BFRG_IncreaseDecreaseInSublicensePercentageBasedOnRevenues
Namespace Prefix:	BFRG_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	instant

- Definition

Licence initiation fee.

+ References

No definition available.

+ Details

Name:	BFRG_LicenceInitiationFee
Namespace Prefix:	BFRG_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Percentage of royalty on net sales.

+ References

No definition available.

+ Details

Name:	BFRG_PercentageOfRoyaltyOnNetSales
Namespace Prefix:	BFRG_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	instant

- Definition

Percentage of warrant issued.

+ References

No definition available.

+ Details

Name:	BFRG_PercentageOfWarrantIssued
Namespace Prefix:	BFRG_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	instant

- Definition

Percentage of sublicense.

+ References

No definition available.

+ Details

Name:	BFRG_SublicensePercentage
Namespace Prefix:	BFRG_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	instant

- Definition

Upfront licence fee.

+ References

No definition available.

+ Details

Name:	BFRG_UpfrontLicenceFee
Namespace Prefix:	BFRG_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Carrying value as of the balance sheet date of obligations incurred through that date and payable for royalties.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 942
-SubTopic 210
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-03.15(5))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1

+ Details

Name:	us-gaap_AccruedRoyaltiesCurrentAndNoncurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 808
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (d)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479402/808-10-50-1

+ Details

Name:	us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Cost of maintenance incurred and directly related to good produced and service rendered.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(b)(2))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2

+ Details

Name:	us-gaap_CostMaintenance
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.20)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1

+ Details

Name:	us-gaap_OtherAccruedLiabilitiesCurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Amount of cash outflow for fees classified as other.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 45
-Paragraph 25
-Subparagraph (g)
-SubTopic 10
-Topic 230
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482740/230-10-45-25

+ Details

Name:	us-gaap_PaymentsForFees
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The amount of cash paid for royalties during the current period.

+ References

+ Details

Name:	us-gaap_PaymentsForRoyalties
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.3)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2

+ Details

Name:	us-gaap_RoyaltyExpense
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Number of new stock issued during the period.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-SubTopic 10
-Topic 505
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481112/505-10-50-2

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 505
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147481004/946-505-50-2

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.6-09(4)(b))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 3
-Subparagraph (SX 210.6-03(i)(1))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 210
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1

+ Details

Name:	us-gaap_StockIssuedDuringPeriodSharesNewIssues
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	us-gaap_TypeOfArrangementAxis=BFRG_JHUAPLTechnologyLicenseAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_AwardDateAxis=BFRG_YearTwentyTwentyTwoMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_AwardDateAxis=BFRG_YearTwentyTwentyThreeMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_AwardDateAxis=BFRG_YearTwentyTwentyFourMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=BFRG_NewLicenseAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_RangeAxis=srt_MaximumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_RangeAxis=srt_MinimumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis=BFRG_InternallyDevelopmentDrugProjectsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_TitleOfIndividualAxis=BFRG_OtherPartiesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_AwardDateAxis=BFRG_YearTwentyTwentyFiveMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_AwardDateAxis=BFRG_YearTwentyTwentySixMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_AwardDateAxis=BFRG_YearTwentyTwentySevenMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=BFRG_GeorgeWashingtonUniversityBeta2SpectrinSiRNALicenseMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=BFRG_JohnsHopkinsUniversityMebendazoleLicenseMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=BFRG_JohnsHopkinsUniversityProdrugLicenseMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_AwardDateAxis=BFRG_YearTwentyTwentyEightMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_AwardDateAxis=BFRG_YearTwentyTwentyNineMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_AwardDateAxis=BFRG_YearTwentyThirtyMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_AwardDateAxis=BFRG_YearTwentyThirtyOneMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=BFRG_LicenseAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Material Agreements (Details Narrative) - USD ($)						1 Months Ended
Material Agreements (Details Narrative) - USD ($)	May 31, 2023	Feb. 28, 2023	Oct. 13, 2022	Jul. 08, 2022	Feb. 22, 2022	Oct. 31, 2021	Dec. 31, 2023	Dec. 31, 2022	Jan. 14, 2022
JHU - APL Technology License Agreement [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Warrant percent						5.00%
Royalty percent						8.00%
Percentage of sublicense						50.00%
Maintenance fee						$ 1,500
JHU - APL Technology License Agreement [Member] \| 2022 [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Royalty payments						20,000
JHU - APL Technology License Agreement [Member] \| 2023 [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Royalty payments						80,000
JHU - APL Technology License Agreement [Member] \| 2024 [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Royalty payments						$ 300,000
New License Agreement [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Royalty payments	$ 275,000
Common stock issued				39,879
Accrued royalty expenses							$ 0	$ 0
New License Agreement [Member] \| Maximum [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Percentage of sublicense				50.00%
New License Agreement [Member] \| Minimum [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Sublicense fee based on revenue				25.00%
New License Agreement [Member] \| Internally Development Drug Projects [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Royalty percent				3.00%
New License Agreement [Member] \| Other Parties [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Royalty percent				8.00%
New License Agreement [Member] \| 2022 [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Royalty payments	60,000			$ 30,000
New License Agreement [Member] \| 2023 [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Royalty payments	75,000			60,000
Accrued royalty expenses							60,000
New License Agreement [Member] \| 2024 [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Royalty payments				$ 300,000
New License Agreement [Member] \| 2025 [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Royalty payments	75,000
New License Agreement [Member] \| 2026 [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Royalty payments	75,000
New License Agreement [Member] \| 2027 [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Royalty payments	$ 50,000
George Washington University - Beta2-spectrin siRNA License Agreement [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Royalty percent									3.00%
Licence initiation fee									$ 20,000
Johns Hopkins University - Mebendazole License Agreement [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Royalty percent					3.50%
Accrued royalty expenses							10,000	242,671
Upfront licence fee					$ 250,000
License fee initial payment		$ 200,000			50,000
Annual minimum royalty payment					250,000
Johns Hopkins University - Mebendazole License Agreement [Member] \| 2023 [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Royalty payments					5,000
Johns Hopkins University - Mebendazole License Agreement [Member] \| 2024 [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Royalty payments					10,000
Johns Hopkins University - Mebendazole License Agreement [Member] \| 2025 [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Royalty payments					20,000
Johns Hopkins University - Mebendazole License Agreement [Member] \| 2026 [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Royalty payments					30,000
Johns Hopkins University - Mebendazole License Agreement [Member] \| 2027 [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Royalty payments					$ 50,000
Johns Hopkins University - Prodrug License Agreement [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Royalty percent			4.00%
Upfront licence fee			$ 100,000
Annual minimum royalty payment			150,000
Johns Hopkins University - Prodrug License Agreement [Member] \| 2027 [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Royalty payments			5,000
Johns Hopkins University - Prodrug License Agreement [Member] \| 2028 [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Royalty payments			10,000
Johns Hopkins University - Prodrug License Agreement [Member] \| 2029 [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Royalty payments			20,000
Johns Hopkins University - Prodrug License Agreement [Member] \| 2030 [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Royalty payments			30,000
Johns Hopkins University - Prodrug License Agreement [Member] \| 2031 [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Royalty payments			$ 50,000
License Agreement [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Accrued expense							$ 0	$ 133,238